opioid-induced constipation

An alternative treatment for OICA new study examines an alternative to current treatments of OIC in abdominoplasty patients.
Keep your patient moving: An overview of treatment options for constipation
Keep your patient moving: An overview of treatment options for constipationThe role of new agents such as linaclotide, lubiprostone, methylnaltrexone, and naloxegol in treating chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation.
FDA approves subcutaneous injection for opioid-induced constipation in chronic non-cancer painFDA approved methylnaltrexone bromide (Relistor, Salix Pharmaceuticals and Progenics Pharmaceuticals) subcutaneous injection, 12 mg/0.6 mL, for the treatment of opioid-induced constipation (OIC) in patients taking opioids for chronic non-cancer pain.
New drug approved by FDA for treatment of opioid-induced constipationFDA has approved a new treatment option for opioid-induced constipation in adult patients with chronic noncancer pain. Naloxegol (Movantik, AstraZeneca) tablets C-II is the first once-daily, oral, peripherally acting ยต-opioid receptor antagonist (PAMORA) to be approved for this condition.
FDA drug approvals-September 2014FDA actions in brief, fast-track designations,priority review, orphan drug designations
FDA approves first oral agent for OIC in adults with chronic noncancer painFDA has approved a supplemental new drug application (sNDA) for lubiprostone (Amitiza, Sucampo Pharmaceuticals and Takeda Pharmaceuticals) 24 ?g twice daily as the first oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, noncancer pain.
FDA approves first oral agent for OIC in adults with chronic noncancer painFDA has approved a supplemental new drug application (sNDA) for lubiprostone (Amitiza, Sucampo Pharmaceuticals and Takeda Pharmaceuticals) 24 ?g twice daily as the first oral medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, noncancer pain.